Business News • PR NewsWire • BioVentrix announces the 1st Revivent TC™ TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment in the Netherlands

BioVentrix announces the 1st Revivent TC™ TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment in the Netherlands

BioVentrix announces the 1st Revivent TC™ TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment in the Netherlands

SAN RAMON, Calif., and NIEUWEGEIN, Netherlands, Nov. 21, 2016 /PRNewswire/ -- BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced the first clinical use in the Netherlands of its closed-chest Revivent TC™...

View More : http://www.prnewswire.com/news-releases/bioventrix-announces-the-1st-revivent-tc-transcatheter-ventricular-enhancement-p...

Releted News by prnewswire

Honda y FCA presentan segunda cumbre sobre mejores prácticas de retiros del mercado en el sector automovilístico por motivos de seguridad

Yanji es el nuevo eje de inversión en el noreste asiático